MAPKs and their relevance to arthritis and inflammation

Rheumatology
T ThalhamerM M Harnett

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which imbalances in pro- and anti-inflammatory cytokines promote the induction of autoimmunity, inflammation and joint destruction. The importance of inflammatory cytokines in the pathogenesis of RA has been underscored by the success of biologics that act to block the effects of cytokines, such as tumour necrosis factor-alpha, interleukin (IL)-1 or IL-6, in treating disease. Mitogen-activated protein kinases (MAPKs) have been implicated as playing key regulatory roles in the production of these pro-inflammatory cytokines and downstream signalling events leading to joint inflammation and destruction. This article reviews the evidence that MAPKs play important roles in the pathogenesis of RA and discusses their therapeutic potential as drug targets.

Citations

Nov 21, 2012·Immunology and Cell Biology·Harriet B TaylorMargaret J Dallman
Aug 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kazuhiko ArimaKoh-Ichiro Yoshiura
Oct 28, 2009·Rheumatology·Carole L GalliganEleanor N Fish
May 29, 2009·Annals of the Rheumatic Diseases·Akihisa FukushimaGary S Firestein
Apr 1, 2010·Cancer Research·Hengning KeJennifer Y Zhang
Oct 20, 2010·Arthritis Research & Therapy·Caroline CharpinIsabelle Auger
May 10, 2011·Arthritis Research & Therapy·Kiyoshi MigitaHiromi Ishibashi
Jun 6, 2012·Journal of Applied Oral Science : Revista FOB·João Antonio Chaves de SouzaJoni Augusto Cirelli
Jun 2, 2012·Journal of the American Society of Nephrology : JASN·Yoshihisa OgawaKazuwa Nakao
Oct 13, 2012·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Ryoichi HayakawaHidenori Ichijo
Apr 12, 2013·Future Medicinal Chemistry·Piotr P Graczyk
Jan 10, 2014·International Immunology·Adel R A Abd-AllahSabry M Attia
Mar 13, 2014·Laboratory Investigation; a Journal of Technical Methods and Pathology·Hiroki KawanoTaiji Sakamoto
Jun 15, 2012·Expert Opinion on Investigational Drugs·Ian P Salt, Timothy M Palmer
Jun 10, 2014·Current Eye Research·Kai KaarnirantaAnu Kauppinen
Dec 3, 2015·Pharmacology & Therapeutics·Thomas HankeManfred Schubert-Zsilavecz
Aug 14, 2012·Arthritis·Ana Cecilia Machado DiazAlicia Santos Savio
Jun 6, 2007·Acta Clinica Belgica·D Blockmans, F Houssiau
Mar 22, 2014·International Journal of Cell Biology·Italo Mario CesariFranklin David Rumjanek
Jan 21, 2014·Autoimmunity·Abdullah Alghasham, Zafar Rasheed
Sep 5, 2015·Mediators of Inflammation·Samuel García, Carmen Conde
Nov 16, 2011·Expert Opinion on Therapeutic Patents·Stefan FischerStefan A Laufer
Jun 2, 2012·Scandinavian Journal of Rheumatology·T AlanäräH Repo
Oct 9, 2014·The Journal of Nutritional Biochemistry·María Ángeles RosilloMaría Luisa Ferrándiz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here